ENAVOgliflozin Outcome Trial in Patients With Severe Aortic Stenosis After Transcatheter Aortic Valve Replacement

PHASE4RecruitingINTERVENTIONAL
Enrollment

1,040

Participants

Timeline

Start Date

December 18, 2024

Primary Completion Date

December 31, 2026

Study Completion Date

April 30, 2027

Conditions
Aortic Valve StenosisHeart Failure
Interventions
DRUG

Enavogliflozin

0.3 mg 1 tablet once daily

DRUG

Standard-of-Care

Standard-of-Care medical therapy plus Enavogliflozin matching placebo

Trial Locations (31)

Unknown

RECRUITING

Bucheon Sejong Hospital, Bucheon-si

NOT_YET_RECRUITING

Gyeongsang National University Changwon Hospital, Changwon

RECRUITING

Daegu Catholic University Medical Center, Daegu

RECRUITING

Keimyung University Dongsan Medical Center, Daegu

NOT_YET_RECRUITING

Kyungpook National University Hospital, Daegu

NOT_YET_RECRUITING

Yeungnam University Medical Center, Daegu

RECRUITING

Chungnam National University Hospital, Daejeon

NOT_YET_RECRUITING

The Catholic University of Korea, Daejeon ST. Mary's Hospital, Daejeon

NOT_YET_RECRUITING

Gangneung Asan Hospital, Gangneung

RECRUITING

Chonnam National University Hospital, Gwangju

NOT_YET_RECRUITING

Inje University Ilsan Paik Hospital, Ilsan

NOT_YET_RECRUITING

Gachon University Gil Hospital, Incheon

NOT_YET_RECRUITING

Incheon Sejong Hospital, Incheon

RECRUITING

Inha University Hospital, Incheon

NOT_YET_RECRUITING

The Catholic University of Korea, Incheon St. Mary's Hospital, Incheon

RECRUITING

Dong-A Medical Center, Pusan

NOT_YET_RECRUITING

Inje University Pusan Paik Hospital, Pusan

NOT_YET_RECRUITING

Pusan National University Hospital, Pusan

NOT_YET_RECRUITING

Seoul university Bundang hospital, Seongnam-si

RECRUITING

Asan Medical Center, Seoul

RECRUITING

Ewha Womans University Mokdong Hospital, Seoul

RECRUITING

Ewha Womans University Seoul Hospital, Seoul

RECRUITING

Hanyang University Seoul Hospital, Seoul

NOT_YET_RECRUITING

Konkuk University Medical Center, Seoul

NOT_YET_RECRUITING

Korea University Anam Hospital, Seoul

NOT_YET_RECRUITING

Korea University Guro Hospital, Seoul

NOT_YET_RECRUITING

SNU Boramae Medical Center, Seoul

RECRUITING

The Catholic Univ. of Korea Eunpyeong St. Mary's hospital, Seoul

NOT_YET_RECRUITING

The Catholic University of Korea, ST. Vincent's Hospital, Suwon

NOT_YET_RECRUITING

Uijeongbu Eulji Medical Center, Eulji University, Uijeongbu-si

NOT_YET_RECRUITING

Ulsan University Hospital, Ulsan

Sponsors
All Listed Sponsors
collaborator

CardioVascular Research Foundation, Korea

OTHER

collaborator

Daewoong Pharmaceutical Co. LTD.

INDUSTRY

lead

Duk-Woo Park, MD

OTHER

NCT05672836 - ENAVOgliflozin Outcome Trial in Patients With Severe Aortic Stenosis After Transcatheter Aortic Valve Replacement | Biotech Hunter | Biotech Hunter